Effectiveness and safety of low-dose oral minoxidil in male androgenetic alopecia

J Am Acad Dermatol. 2019 Aug;81(2):648-649. doi: 10.1016/j.jaad.2019.04.054. Epub 2019 May 2.

Authors

Juan Jimenez-Cauhe¹, David Saceda-Corralo², Rita Rodrigues-Barata², Angela Hermosa-Gelbard³, Oscar M Moreno-Arrones², Diego Fernandez-Nieto³, Sergio Vaño-Galvan²

Affiliations

¹ Dermatology Department, Trichology Unit, Ramon y Cajal University Hospital, Madrid, Spain. Electronic address: jjimenezc92@gmail.com.
² Dermatology Department, Trichology Unit, Ramon y Cajal University Hospital, Madrid, Spain; Trichology Unit, Grupo de Dermatología Pedro Jaen, Madrid, Spain.
³ Dermatology Department, Trichology Unit, Ramon y Cajal University Hospital, Madrid, Spain.

PMID: 31054970
DOI: 10.1016/j.jaad.2019.04.054

No abstract available

Publication types

Letter

MeSH terms

Administration, Oral
Adult
Alopecia / drug therapy*
Humans
Male
Middle Aged
Minoxidil / administration & dosage*
Minoxidil / adverse effects
Retrospective Studies
Severity of Illness Index
Treatment Outcome
Vasodilator Agents / administration & dosage*
Vasodilator Agents / adverse effects
Young Adult

Substances

Vasodilator Agents
Minoxidil